본문 바로가기
KERD
논문KCI 등재

One-Year Outcomes of Ab Externo XEN45 Gel Stent Implantation with an Open Conjunctiva Approach in Patients with Open-Angle Glaucoma

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류안과학

초록

Purpose: This study aimed to evaluate the 1-year surgical outcomes of XEN45 gel stent implantation with an open conjunctiva approach in patients with open-angle glaucoma (OAG). Methods: This retrospective cohort study included 19 eyes of 19 patients who underwent XEN45 gel stent implantation with an open conjunctival approach. Surgical success was defined by intraocular pressure (IOP) ≤18 mmHg and one of the following: IOP reduction ≥30% or reduction of two glaucoma medications with final IOP if baseline IOP ≤18 mmHg. The cumulative probability of success rate was analyzed using Kaplan-Meier survival analysis. Cox proportional hazard regression analysis was used to assess prognostic factors for surgical failure. Results: IOP reduced from 32.37 ± 12.08 mmHg preoperatively to 15.14 ± 2.25 mmHg at 1 year (p = 0.001). The number of glaucoma medication reduced from 3.89 ± 0.32 preoperatively to 0.86 ± 1.35 at 1 year (p = 0.001). The success rates were 78.9% at 6 months and 73.7% at 1 year. Eyes with bleb horizontal extent ≥2 clock hours at 1 month postoperatively had a significantly higher success rate (log-rank test, p < 0.001). Greater bleb horizontal extent at 2 weeks and 1 month postoperatively was associated with a lower surgical failure rate (2 weeks: hazard ratio, 0.119; p = 0.024; 1 month: hazard ratio, 0.046; p = 0.007). Bleb needling and additional glaucoma surgeries were necessary in 10 (52.6%) and five eyes (26.3%), respectively. Conclusions: XEN45 gel stent implantation with the open conjunctiva approach is effective in reducing IOP and glaucoma medication for over 1 year in patients with OAG.

Abstract

Purpose: This study aimed to evaluate the 1-year surgical outcomes of XEN45 gel stent implantation with an open conjunctiva approach in patients with open-angle glaucoma (OAG). Methods: This retrospective cohort study included 19 eyes of 19 patients who underwent XEN45 gel stent implantation with an open conjunctival approach. Surgical success was defined by intraocular pressure (IOP) ≤18 mmHg and one of the following: IOP reduction ≥30% or reduction of two glaucoma medications with final IOP if baseline IOP ≤18 mmHg. The cumulative probability of success rate was analyzed using Kaplan-Meier survival analysis. Cox proportional hazard regression analysis was used to assess prognostic factors for surgical failure. Results: IOP reduced from 32.37 ± 12.08 mmHg preoperatively to 15.14 ± 2.25 mmHg at 1 year (p = 0.001). The number of glaucoma medication reduced from 3.89 ± 0.32 preoperatively to 0.86 ± 1.35 at 1 year (p = 0.001). The success rates were 78.9% at 6 months and 73.7% at 1 year. Eyes with bleb horizontal extent ≥2 clock hours at 1 month postoperatively had a significantly higher success rate (log-rank test, p < 0.001). Greater bleb horizontal extent at 2 weeks and 1 month postoperatively was associated with a lower surgical failure rate (2 weeks: hazard ratio, 0.119; p = 0.024; 1 month: hazard ratio, 0.046; p = 0.007). Bleb needling and additional glaucoma surgeries were necessary in 10 (52.6%) and five eyes (26.3%), respectively. Conclusions: XEN45 gel stent implantation with the open conjunctiva approach is effective in reducing IOP and glaucoma medication for over 1 year in patients with OAG.

참고문헌 (37)

  1. Khaw PT, "Enhanced trabeculectomy : the Moorfields Safer Surgery System", Dev Ophthalmol, 50, pp.1~28 (2012)
  2. Rulli E, "Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures : a systematic review and meta-analysis", JAMA Ophthalmol, 131, pp.1573~1582 (2013)
  3. Higginbotham EJ, "Bleb-related endophthalmitis after trabeculectomy with mitomycin C", Ophthalmology, 103, pp.650~656 (1996)
  4. Schlenker MB, "Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy", Ophthalmology, 124, pp.1579~1588 (2017)
  5. Buffault J, "Efficacy and safety at 6 months of the XEN implant for the management of open angle glaucoma", Sci Rep, 10, pp.4527~ (2020)
  6. Hohberger B, "MIGS : therapeutic success of combined XEN gel stent implantation with cataract surgery", Graefes Arch Clin Exp Ophthalmol, 256, pp.621~625 (2018)
  7. Karimi A, "A multi-centre interventional case series of 259 ab-interno Xen gel implants for glaucoma, with and without combined cataract surgery", Eye(Lond), 33, pp.469~477 (2019)
  8. Duzgun E, "Outcomes of XEN gel stent implantation in the inferonasal quadrant after failed trabeculectomy", J Curr Glaucoma Pract, 15, pp.64~69 (2021)
  9. Vera V, "Surgical approaches for implanting XEN gel stent without conjunctival dissection", Clin Ophthalmol, 14, pp.2361~2371 (2020)
  10. Panarelli JF, "XEN gel stent open conjunctiva technique : a practical approach paper", Adv Ther, 37, pp.2538~2549 (2020)
  11. Tan NE, "Comparison of safety and efficacy between ab interno and ab externo approaches to XEN gel stent placement", Clin Ophthalmol, 15, pp.299~305 (2021)
  12. Do A, "Comparison of clinical outcomes with open versus closed conjunctiva implantation of the XEN45 gel stent", Ophthalmol Glaucoma, 4, pp.343~349 (2021)
  13. Park J, "Comparison of surgical outcomes with and without Ologen collagen matrix augmentation during XEN gel stent implantation", BMC Ophthalmol, 22, pp.426~ (2022)
  14. Broadway D, "Racial differences in the results of glaucoma filtration surgery : are racial differences in the conjunctival cell profile important?", Br J Ophthalmol, 78, pp.466~475 (1994)
  15. Husain R, "A review of trabeculectomy in East Asian people: the influence of race", Eye(Lond), 19, pp.243~252 (2005)
  16. Han SB, "Prevalence and risk factors of myopia in adult Korean population : Korea national health and nutrition examination survey 2013-2014(KNHANES VI)", PLoS One, 14, pp.e0211204~ (2019)
  17. Schraermeyer U, "Morphologic proof of the toxicity of mitomycin C on the ciliary body in relation to different application methods", Graefes Arch Clin Exp Ophthalmol, 237, pp.593~600 (1999)
  18. Foster PJ, "The definition and classification of glaucoma in prevalence surveys", Br J Ophthalmol, 86, pp.238~242 (2002)
  19. Cantor LB, "Morphologic classification of filtering blebs after glaucoma filtration surgery : the Indiana Bleb Appearance Grading Scale", J Glaucoma, 12, pp.266~271 (2003)
  20. Romero P, "Trabeculectomy with mitomycin-C : outcomes and risk factors for failure in primary angle-closure glaucoma", J Glaucoma, 27, pp.101~107 (2018)
  21. Shaarawy T, "Guidelines on design and reporting of glaucoma surgical trials" (2009), Kugler publications
  22. Cook JA, "Systematic review of the agreement of tonometers with Goldmann applanation tonometry", Ophthalmology, 119, pp.1552~1557 (2012)
  23. Gedde SJ, "Treatment outcomes in the Tube Versus Trabeculectomy(TVT)study after five years of follow-up", Am J Ophthalmol, 153, pp.789~803 (2012)
  24. Alwitry A, "Early bleb leak after trabeculectomy and prognosis for bleb failure", Eye(Lond), 23, pp.858~863 (2009)
  25. Anderson DR, "Natural history of normal-tension glaucoma", Ophthalmology, 108, pp.247~253 (2001)
  26. Ritch R, "Why is glaucoma associated with exfoliation syndrome?", Prog Retin Eye Res, 22, pp.253~275 (2003)
  27. Lim SH, "Long-term outcomes of mitomycin-c trabeculectomy in exfoliative glaucoma versus primary open-angle glaucoma", J Glaucoma, 26, pp.303~310 (2017)
  28. Konstas AG, "Factors associated with long-term progression or stability in exfoliation glaucoma", Arch Ophthalmol, 122, pp.29~33 (2004)
  29. Kim Y, "Bleb analysis using anterior segment optical coherence tomography and surgical predictors of XEN gel stent", Transl Vis Sci Technol, 11, pp.26~ (2022)
  30. Grover DS, "Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months", Am J Ophthalmol, 183, pp.25~36 (2017)
  31. Costa VP, "Loss of visual acuity after trabeculectomy", Ophthalmology, 100, pp.599~612 (1993)
  32. Hylton C, "Cataract after glaucoma filtration surgery", Am J Ophthalmol, 135, pp.231~232 (2003)
  33. Gedde SJ, "Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up", Am J Ophthalmol, 143, pp.9~22 (2007)
  34. Kirwan JF, "Trabeculectomy in the 21st century : a multicenter analysis", Ophthalmology, 120, pp.2532~2539 (2013)
  35. Stamper RL, "Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil", Am J Ophthalmol, 114, pp.544~553 (1992)
  36. Waibel S, "Bleb morphology after mitomycin-C augmented trabeculectomy : comparison between clinical evaluation and anterior segment optical coherence tomography", J Glaucoma, 28, pp.447~451 (2019)
  37. Lenzhofer M, "Longitudinal bleb morphology in anterior segment OCT after minimally invasive transscleral ab interno Glaucoma Gel Microstent implantation", Acta Ophthalmol, 97, pp.e231~7 (2019)

관련 논문AI추천

이 간행물의 다른 논문 (11건)